{"id":"fluticasone-furoate-fexofenadine","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Pharyngitis"},{"rate":null,"effect":"Epistaxis"},{"rate":null,"effect":"Dysphonia"},{"rate":null,"effect":"Tremor"}]},"_chembl":{"chemblId":"CHEMBL1676","moleculeType":"Small molecule","molecularWeight":"538.58"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fluticasone furoate is an inhaled corticosteroid that binds to glucocorticoid receptors in the airway, suppressing inflammatory cytokine production and reducing mucosal inflammation. Fexofenadine is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses without significant central nervous system penetration. Together, they address both the inflammatory and allergic components of respiratory allergic disease.","oneSentence":"This combination product delivers a corticosteroid that reduces airway inflammation and an antihistamine that blocks allergic responses to treat allergic rhinitis and asthma.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:40:28.166Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis"},{"name":"Asthma (in combination therapy)"}]},"trialDetails":[{"nctId":"NCT00435461","phase":"PHASE4","title":"Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-12-20","conditions":"Rhinitis, Allergic, Seasonal","enrollment":1000},{"nctId":"NCT00502775","phase":"PHASE4","title":"Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-08","conditions":"Rhinitis, Allergic, Seasonal","enrollment":680}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["fluticasone furoate","fexofenadine"],"phase":"marketed","status":"active","brandName":"fluticasone furoate, fexofenadine","genericName":"fluticasone furoate, fexofenadine","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination product delivers a corticosteroid that reduces airway inflammation and an antihistamine that blocks allergic responses to treat allergic rhinitis and asthma. Used for Allergic rhinitis, Asthma (in combination therapy).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}